NCT02708966View on ClinicalTrials.gov

Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance.

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

October 31, 2018

Conditions
Impaired Glucose Tolerance
Interventions
DRUG

Gymnema Sylvestre

Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner

DRUG

Placebo

Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner

Trial Locations (1)

44340

Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT02708966 - Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance. | Biotech Hunter | Biotech Hunter